Myeloma bone disease

被引：112

作者：

Callander, NS

Roodman, GD

机构：

[1] Audie L Murphy Mem Vet Adm Med Ctr, Res Serv 151, San Antonio, TX 78284 USA

[2] Univ Texas, Hlth Sci Ctr, Dept Med Hematol, San Antonio, TX 78284 USA

来源：

SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 03期

关键词：

D O I：

10.1053/shem.2001.26007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：276 / 285

页数：10

共 102 条

[1] Abe M, 1999, J BONE MINER RES, V14, pS163
[2] Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma
Abildgaard, N
Glerup, H
Rungby, J
Bendix-Hansen, K
Kassem, M
Brixen, K
Heickendorff, L
Nielsen, JL
Eriksen, EF
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (02) : 121 - 129
[3] Abildgaard N, 1996, EUR J HAEMATOL, V57, P370
[4] Development of an in vivo model of human multiple myeloma bone disease
Alsina, M
Boyce, B
Devlin, RD
Anderson, JL
Craig, F
Mundy, GR
Roodman, GD
[J]. BLOOD, 1996, 87 (04) : 1495 - 1501
[5] BALLESTER OF, 1994, BLOOD, V83, P1903
[6] Barillé S, 1999, J IMMUNOL, V163, P5723
[7] Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells
Barille, S
Akhoundi, C
Collette, M
Mellerin, MP
Rapp, MJ
Harousseau, JL
Bataille, R
Amiot, M
[J]. BLOOD, 1997, 90 (04) : 1649 - 1655
[8] MECHANISMS OF BONE-LESIONS IN MULTIPLE-MYELOMA
BATAILLE, R
CHAPPARD, D
KLEIN, B
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) : 285 - 295
[9] BIOLOGIC EFFECTS OF ANTI-INTERLEUKIN-6 MURINE MONOCLONAL-ANTIBODY IN ADVANCED MULTIPLE-MYELOMA
BATAILLE, R
BARLOGIE, B
LU, ZY
ROSSI, JF
LAVABREBERTRAND, T
BECK, T
WIJDENES, J
BROCHIER, J
KLEIN, B
[J]. BLOOD, 1995, 86 (02) : 685 - 691
[10] SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS
BATAILLE, R
JOURDAN, M
ZHANG, XG
KLEIN, B
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) : 2008 - 2011

← 1 2 3 4 5 6 7 8 9 10 →